CUBE vs SPRO
CubeSmart (CUBE) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the CUBE and SPRO stock pages for the full models.
Not investment advice.